A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis of paying illegal kickbacks ...

A U.S. court of appeals has reportedly ruled that a whistleblower case against Novartis (NVS) over alleged kickbacks ...

Recent health developments include a new injectable cancer drug by Bristol Myers Squibb, a revived lawsuit against Novartis ...

Novartis agreed in 2020 to pay more than $729 million to settle U.S. government charges it paid illegal kickbacks to doctors and patients to boost drug sales. The case is US ex rel Camburn v.

NEW YORK (Reuters) -A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis of paying illegal kickbacks to doctors to induce them to promote its blockbuster ...

Mr. Camburn, a former Novartis sales executive, claims the company used speaker events and excessive compensation to influence doctors' prescribing practices, violating the Antitrust Kickback Statute.

Recent health developments include the FDA's approval of an injectable version of Bristol Myers Squibb's cancer drug Opdivo.